X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 55 filers reported holding X4 PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,528,941 | -43.5% | 7,824,717 | +0.5% | 0.00% | – |
Q2 2023 | $15,107,052 | +299.7% | 7,787,140 | +79.2% | 0.00% | – |
Q1 2023 | $3,779,551 | +6.3% | 4,344,311 | +21.3% | 0.00% | – |
Q4 2022 | $3,555,326 | -35.2% | 3,580,389 | +11.6% | 0.00% | – |
Q3 2022 | $5,486,000 | +695.1% | 3,208,103 | +348.6% | 0.00% | – |
Q2 2022 | $690,000 | -39.7% | 715,175 | +9.5% | 0.00% | – |
Q1 2022 | $1,144,000 | -46.5% | 653,185 | -30.0% | 0.00% | – |
Q4 2021 | $2,137,000 | -56.8% | 933,240 | -0.1% | 0.00% | – |
Q3 2021 | $4,942,000 | -15.3% | 934,352 | +4.1% | 0.00% | – |
Q2 2021 | $5,834,000 | -8.0% | 897,641 | +21.9% | 0.00% | – |
Q1 2021 | $6,343,000 | +34.2% | 736,602 | +0.2% | 0.00% | – |
Q4 2020 | $4,726,000 | -2.7% | 734,966 | +2.4% | 0.00% | – |
Q3 2020 | $4,857,000 | -27.7% | 717,392 | -0.4% | 0.00% | – |
Q2 2020 | $6,716,000 | -9.1% | 720,625 | -2.5% | 0.00% | – |
Q1 2020 | $7,391,000 | -4.1% | 739,048 | +2.5% | 0.00% | – |
Q4 2019 | $7,711,000 | +11.9% | 720,686 | +33.0% | 0.00% | – |
Q3 2019 | $6,888,000 | -12.2% | 541,925 | +3.7% | 0.00% | – |
Q2 2019 | $7,842,000 | +422.1% | 522,811 | +506.0% | 0.00% | – |
Q1 2019 | $1,502,000 | – | 86,272 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |